Mergers & TribulationsTransaction Database
ContactSubscribe
Back to database

Deal Detail

Melissa & Doug to Spin Master Corp.

HHP/Pers Care/Oct 2023
EV / LTM EBITDA
10.5x
EV / LTM Sales
1.9x
Enterprise Value
$950M
Primary Source
Company Release

Comparable Transactions

HHP/Pers Care transactions announced in the five years to October 2023. 18 with a disclosed multiple.

DateTargetAcquirorEnterprise ValueEV/SalesEV/EBITDAType
Aug 2023Naturium LLCe.l.f. Beauty, Inc.--21.0xStrategic
Sep 2022Hero CosmeticsChurch & Dwight$630M5.5x14.0xStrategic
Apr 2022Recipe Products Ltd.Helen of Troy Limited$150M-10.0xStrategic
Nov 2021Sol de Janeiro Holdings, Inc.L'Occitane International S.A.$450M4.4x20.6xStrategic
Nov 2021Apollo Healthcare Corp.Anjac Health & Beauty$256M2.3x-Strategic
Nov 2021TheraBreathChurch & Dwight$580M6.7x21.5xStrategic
Nov 2021Obagi Global Holdings LimitedWaldencast Acquisition Corp.--17.2xFinancial
Aug 2021bareMinerals, BUXOM, and Laura MercierAdvent International$700M1.7x-Financial
Apr 2021Productos Familia S.A.Essity$1.5B1.9x9.1xStrategic
Feb 2021DECIEMEstée Lauder$2.2B4.8x-Strategic
Jan 2021Georgia-Pacific’s U.S. Nonwovens BusinessGlatfelter Corporation$175M1.8x8.8xStrategic
Sep 2020Officina Profumo Farmaceutica di Santa Maria Novella S.p.A.Italmobiliare$216M5.8x15.1xFinancial
Jun 2020Coty Inc.'s Hair business (Wella, Clairol, OPI and ghd brands)KKR$4.3B-12.3xFinancial
Feb 2020Santher - Fábrica de Papel Santa Therezinha S.A.Daio Paper Corporation and Marubeni Corporation$514M1.5x12.8xStrategic
Dec 2019Drybar Products LLCHelen of Troy Limited$255M-13.0xStrategic
May 2019CoppertoneBeiersdorf AG$550M2.6x-Strategic
May 2019Avon Products, Inc.Natura & Co Holding S.A.--9.5xStrategic
Jan 2019Elemis LtdL'Occitane International S.A.$900M6.4x22.6xStrategic
Mean3.8x14.8x
Median3.5x13.5x

All Observations

Source-specific multiples and notes for this transaction.

CompPrimary?Source TypeSourceSource AdvisorSource YearEV (USD)EV/SalesEV/EBITDAEV/Fwd EBITDANoteCitation
Primarypress releasePress Release-2023$950M1.9x10.5x-Excludes $150m earnout. Multiples based on FY22 figures. 8.1x EBITDA including $25-30m runrate cost synergies.Open